MEI Pharma
Utility Patents

Last updated: 8 Sep 2025

Status	Patent	Filling date	Issue date
Grant	Utility: Combination therapy Filling date: 8 Sep 2025 Issue date: 7 Jun 2022	14 Aug 2018	7 Jun 2022
Grant	Utility: Combination therapy Filling date: 8 Sep 2025 Issue date: 19 Apr 2022	22 May 2018	19 Apr 2022
Grant	Utility: Combination therapies Filling date: 8 Sep 2025 Issue date: 20 Apr 2021	1 Feb 2016	20 Apr 2021
Grant	Utility: Isoflavonoid compositions and methods for the treatment of cancer Filling date: 8 Sep 2025 Issue date: 13 Apr 2021	18 Jun 2019	13 Apr 2021
Grant	Utility: Benzimidazole derivatives: preparation and pharmaceutical applications Filling date: 8 Sep 2025 Issue date: 11 Aug 2020	14 Dec 2018	11 Aug 2020
Grant	Utility: Polymorphic forms of 3-[(2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acr- ylamide and uses thereof Filling date: 8 Sep 2025 Issue date: 21 Apr 2020	1 May 2017	21 Apr 2020
Grant	Utility: (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases Filling date: 8 Sep 2025 Issue date: 31 Mar 2020	19 Apr 2019	31 Mar 2020
Grant	Utility: Isoflavonoid compositions and methods for the treatment of cancer Filling date: 8 Sep 2025 Issue date: 6 Aug 2019	24 Apr 2018	6 Aug 2019

Showing 1 to 8 of 8 patents.